Induced pluripotent stem cells, new tools for drug discovery and new hope for stem cell therapies

Current Molecular Pharmacology

Volumn 2, Issue 1, 2009, Pages 15-18

  Shi, Yanhong ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Embryonic stem (ES) cells; Induced pluripotent stem (iPS) cells; Pluripotency; Regenerative medicine; Reprogramming; Stem cell therapy

Indexed keywords

ARTICLE; CELL TYPE; DRUG DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; GERM LAYER; HUMAN; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SOMATIC CELL; STEM CELL TRANSPLANTATION; ANIMAL; CYTOLOGY; EMBRYONIC STEM CELL; METABOLISM; MOUSE; REGENERATIVE MEDICINE; REVIEW;

ANIMALS; DRUG DISCOVERY; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 77449141188     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467210902010015     Document Type: Article

References (35)

1. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
2. Wakayama, T.; Tabar, V.; Rodriguez, I.; Perry, A. C.; Studer, L.; Mombaerts, P. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001, 292, 740-743.
3. Egli, D.; Rosains, J.; Birkhoff, G.; Eggan, K. Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 2007, 447, 679-685.
4. Tada, M.; Takahama, Y.; Abe, K.; Nakatsuji, N.; Tada, T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 2001, 11, 1553-1558.
5. Cowan, C. A.; Atienza, J.; Melton, D. A.; Eggan, K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309, 1369-1373.
6. Jaenisch, R. Human cloning - the science and ethics of nuclear transplantation. N. Engl. J. Med. 2004, 351, 2787-2791.
7. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
8. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448, 313-317.
9. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B. E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448, 318-324.
10. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.;Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1, 55-70.
11. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fi- broblasts by defined factors. Cell 2007, 131, 861-872.
12. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Slukvin, II; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
13. Park, I. H.; Zhao, R.; West, J. A.; Yabuuchi, A.; Huo, H.; Ince, T. A.; Lerou, P. H.; Lensch, M. W.; Daley, G. Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451, 141-146.
14. Zaehres, H.; Scholer, H. R. Induction of pluripotency: from mouse to human. Cell 2007, 131, 834-835.
15. Nichols, J.; Zevnik, B.; Anastassiadis, K.; Niwa, H.; Klewe-Nebenius, D.; Chambers, I.; Scholer, H.; Smith, A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95, 379-391.
16. Niwa, H.; Miyazaki, J.; Smith, A. G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24, 372-376.
17. Avilion, A. A.; Nicolis, S. K.; Pevny, L. H.; Perez, L.; Vivian, N.; Lovell-Badge, R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17, 126-140.
18. Chambers, I.; Colby, D.; Robertson, M.; Nichols, J.; Lee, S.; Tweedie, S.; Smith, A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113, 643-655.
19. Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda, M.; Yamanaka, S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113, 631-642.
20. Matsuda, T.; Nakamura, T.; Nakao, K.; Arai, T.; Katsuki, M.; Heike, T.; Yokota, T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999, 18, 4261-4269.
21. Niwa, H.; Burdon, T.; Chambers, I.; Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12, 2048-2060.
22. Cartwright, P.; McLean, C.; Sheppard, A.; Rivett, D.; Jones, K.; Dalton, S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005, 132, 885-896.
23. Li, Y.; McClintick, J.; Zhong, L.; Edenberg, H. J.; Yoder, M. C.; Chan, R. J. Murine embryonic stem cell differentiation is promoted by SOCS-3 and in- hibited by the zinc finger transcription factor Klf4. Blood 2005, 105, 635-637.
24. Kielman, M. F.; Rindapaa, M.; Gaspar, C.; van Poppel, N.; Breukel, C.; van Leeuwen, S.; Taketo, M. M.; Roberts, S.; Smits, R.; Fodde, R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat. Genet. 2002, 32, 594-605.
25. Sato, N.; Meijer, L.; Skaltsounis, L.; Greengard, P.; Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10, 55-63.
26. Lowry, W. E.; Richter, L.; Yachechko, R.; Pyle, A. D.; Tchieu, J.; Sridharan, R.; Clark, A. T.; Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 2008, 105, 2883-2888.
27. Rao, M. Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Dev. Biol. 2004, 275, 269-286.
28. Aoi, T.; Yae, K.; Nakagawa, M.; Ichisaka, T.; Okita, K.; Takahashi, K.; Chiba, T.; Yamanaka, S. Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells. Science 2008, 321, 699-702.
29. Brambrink, T.; Foreman, R.; Welstead, G. G.; Lengner, C. J.; Wernig, M.; Suh, H.; Jaenisch, R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2, 151-159.
30. Hanna, J.; Markoulaki, S.; Schorderet, P.; Carey, B. W.; Beard, C.; Wernig, M.; Creyghton, M. P.; Steine, E. J.; Cassady, J. P.; Foreman, R.; Lengner, C. J.; Dausman, J. A.; Jaenisch, R. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008, 133, 250-264.
31. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.; Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26, 101-106.
32. Wernig, M.; Meissner, A.; Cassady, J. P.; Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008, 2, 10-12.
33. Stadtfeld, M.; Maherali, N.; Breault, D. T.; Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008, 2, 230-240.
34. Wernig, M.; Zhao, J. P.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 2008, 105, 5856-5861.
35. Hanna, J.; Wernig, M.; Markoulaki, S.; Sun, C. W.; Meissner, A.; Cassady, J. P.; Beard, C.; Brambrink, T.; Wu, L. C.; Townes, T. M.; Jaenisch, R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318, 1920-1923.